|
Market Closed -
Nasdaq
01:30:00 28/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 10.42 USD | -1.79% |
|
-0.48% | +164.47% |
| 21/09 | Turn Therapeutics Inc.(NasdaqGM:TTRX) added to S&P TMI Index | CI |
| 09/09 | Turn Therapeutics Inc. Announces Appointment of Robert R. Redfield as Chief Scientific Officer | CI |
| Market Cap | 31Cr 28Cr 26Cr 23Cr 44Cr 2.95TCr 44Cr 308.39Cr 122.48Cr 1.55TCr 116.51Cr 114.02Cr 4.9TCr | P/E 2026 * |
-22.7x | P/E 2027 * | -23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 31Cr 28Cr 26Cr 23Cr 44Cr 2.95TCr 44Cr 308.39Cr 122.48Cr 1.55TCr 116.51Cr 114.02Cr 4.9TCr | EV / Sales 2026 * |
1,242x | EV / Sales 2027 * | 124x |
| Free-Float |
47.1% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TTRX | Delayed | |
CBOE
| TTRX | Real-time |
| 1 day | -1.79% | ||
| 1 week | -0.48% | ||
| Current month | -27.59% | ||
| 1 month | -16.57% | ||
| 3 months | +33.93% | ||
| 6 months | +181.62% | ||
| Current year | +164.47% |
| 1 week | 9.83 |  | 10.83 |
| 1 month | 9.83 | | 14.63 |
| Current year | 3.01 | | 16.45 |
| 1 year | 2.57 | | 16.45 |
| 3 years | 2.57 | | 26.5 |
| 5 years | 2.57 | | 26.5 |
| 10 years | 2.57 | | 26.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bradley Burnam
CEO | Chief Executive Officer | 48 | 01/10/2018 |
Zuraiz Chaudhary
DFI | Director of Finance/CFO | 31 | 01/05/2025 |
Stephen Hahn
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bradley Burnam
CHM | Chairman | 48 | - |
| Director/Board Member | 47 | 01/10/2018 | |
Andrew Gengos
BRD | Director/Board Member | 62 | 01/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/05/26 | Don | Chief Executive Officer | -12,00,000 | 4.0285% | ||
| 02/04/26 | Don | Chief Executive Officer | 3,00,000 | 1.0188% | ||
| 02/04/26 | Don | Director | 3,00,000 | 1.0188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | -0.48% | +109.66% | - | 31Cr | |
| -3.10% | -4.19% | +32.67% | +59.47% | 6.35TCr | |
| +0.33% | +0.33% | +10.16% | +78.07% | 5.45TCr | |
| +0.16% | +1.73% | +9.89% | +102.10% | 5.36TCr | |
| -0.75% | +1.38% | +24.89% | +50.91% | 4.48TCr | |
| -1.30% | -4.80% | +16.05% | +114.76% | 4.16TCr | |
| +1.26% | -5.26% | +221.12% | +900.64% | 3.99TCr | |
| -0.74% | -4.46% | +11.00% | +44.65% | 3.25TCr | |
| +1.11% | +15.18% | +60.27% | +49.33% | 2.67TCr | |
| +3.99% | -5.95% | +26.39% | -8.00% | 2.34TCr | |
| Average | -0.08% | -1.12% | +52.21% | +154.66% | 3.81TCr | |
| Weighted average by Cap. | -0.28% | -1.27% | +43.03% | +155.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2L 2L 2L 2L 4L 2.37Cr 4L 24.84L 10L 1.24Cr 9L 9L 3.95Cr | 25L 22.44L 20.72L 18.79L 35.11L 24Cr 35.54L 2.48Cr 98.65L 12Cr 93.84L 91.84L 39Cr |
| Net income | -1.55Cr -1.39Cr -1.28Cr -1.16Cr -2.18Cr -147.23Cr -2.2Cr -15Cr -6.12Cr -77Cr -5.82Cr -5.69Cr -244.72Cr | -2.3Cr -2.06Cr -1.91Cr -1.73Cr -3.23Cr -218.47Cr -3.27Cr -23Cr -9.08Cr -114.51Cr -8.63Cr -8.45Cr -363.13Cr |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | $10.42 | -1.79% | 98,415 |
| 26/26/26 | $10.61 | +3.21% | 98,176 |
| 23/26/23 | $10.28 | +0.98% | 87,049 |
| 22/26/22 | $10.18 | +0.30% | 1,13,120 |
| 21/26/21 | $10.15 | -3.06% | 60,584 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.42USD
Average target price
25.00USD
Spread / Average Target
+139.92%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TTRX Stock
Select your edition
All financial news and data tailored to specific country editions
